AGER and neoplasm: reported, that HMGB1 activates the nuclear factor-kappa B (NF-κB) signaling pathway upon binding to the receptor for advanced glycation end products (RAGE) on the tumor cell surface and promotes tumor secretion of IL-8 (29, 30).